Table 1.
Comparison of lineage differentiations of various sources of MSCs.
| Source of MSCs | Osteogenesis | Chondrogenesis | Adipogenesis |
|---|---|---|---|
| BM-MSC | ++++ | +++ | + |
| AD-MSC | ++ | ++ | ++++ |
| HSC | + | +/− | + |
| Pl-MSC | +++ | ++ | ++ |
| Af-MSC | ++ | +++ | ++ |
| PB-MSC | ++ | +++ | ++ |
| Sy-MSC | +++ | ++++ | + |
| D-MSC | ++++ | +++ | + |
| P-MSC | ++++ | +++ | + |
| En-MSC | ++ | ++ | ++ |
| iPSC | +++ | +++ | +++ |
BM-MSC—bone marrow-derived MSC; AD-MSC—adipose tissue-derived MSC; HSC—hematopoietic stem cells; Pl-MSC—placental derived MSC; Af-MSC—amniotic fluid-derived MSC; PB-MSC—peripheral blood-derived MSC; Sy-MSC—synovium-derived MSC; D-MSC—dental tissue-derived MSC; P-MSC—periosteum-derived MSC; En-MSC—menstrual fluid-derived MSC; iPSC—induced pluripotent stem cells. +: low potential; ++: moderate potential; +++: high potential; ++++: very high potential; −: no potential.